Publications

Hirten R, Longman RS, Bosworth BP, Steinlauf A, Scherl E. Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease. Am J Gastroenterol. 2015;110(12):1737-8.

Huang S-H, McCann CD, Mota TM, Wang C, Lipkin SM, R Jones B. Have Cells Harboring the HIV Reservoir Been Immunoedited?. Front Immunol. 2019;10:1842.

Hussain M, Borcard L, Walsh KP, Rodriguez MPena, Mueller C, Kim BS, Kubo M, Artis D, Noti M. Basophil-derived IL-4 promotes epicutaneous antigen sensitization concomitant with the development of food allergy. J Allergy Clin Immunol. 2018;141(1):223-234.e5.

Iliev ID, Lin W-Y, Gaffen SL. When IL-17 gets on your nerves. Cell. 2023;186(3):466-468.

Iliev ID, Leonardi I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol. 2017;17(10):635-646.

Iliev ID. Mycobiota-host immune interactions in IBD: coming out of the shadows. Nat Rev Gastroenterol Hepatol. 2021;.

Iliev ID. Dectin-1 Exerts Dual Control in the Gut. Cell Host Microbe. 2015;18(2):139-41.

Iliev ID, Cadwell K. Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases. Gastroenterology. 2020;.

Irie M, Sasahara K, Artis D, Kabata H. Current overview of the role of neuropeptides in ILC2s and future directions. Allergol Int. 2022;71(3):294-300.

Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V, Ajami NJ, Petrosino JF, Gerardin Y, Kassam Z, Smith M, Iliev ID, Sonnenberg GF, Artis D, Scherl E, Longman RS. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis. Inflamm Bowel Dis. 2017;23(6):903-911.

Jahid S, Sun J, Gelincik O, Blecua P, Edelmann W, Kucherlapati R, Zhou K, Jasin M, Gümüş ZH, Lipkin SM. Inhibition of colorectal cancer genomic copy number alterations and chromosomal fragile site tumor suppressor FHIT and WWOX deletions by DNA mismatch repair. Oncotarget. 2017;8(42):71574-71586.

Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A, Rompe ZA, Stamm A, Tsou AM, Chu C, Heinrich FR, Guerra GM, Durek P, Ivanov A, Beule D, Helfrich S, Duerr CU, Kühl AA, Stehle C, Romagnani C, Mashreghi M-F, Diefenbach A, Artis D, Klose CSN. Non-redundant functions of group 2 innate lymphoid cells. Nature. 2022;611(7937):794-800.

Jin W-B, Li T-T, Huo D, Qu S, Li XV, Arifuzzaman M, Lima SF, Shi H-Q, Wang A, Putzel GG, Longman RS, Artis D, Guo C-J. Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome. Cell. 2022;185(3):547-562.e22.

Jin W-B, Guo C-J. Boosting polyketides production in cell factories: Shared target-pathway for pharmaceutical polyketides engineering. Synth Syst Biotechnol. 2020;5(1):35-36.

Joseph AM, Monticelli LA, Sonnenberg GF. Metabolic regulation of innate and adaptive lymphocyte effector responses. Immunol Rev. 2018;286(1):137-147.

Kabata H, Artis D. Neuro-immune crosstalk and allergic inflammation. J Clin Invest. 2019;130:1475-1482.

Kabata H, Flamar A-L, Mahlakõiv T, Moriyama S, Rodewald H-R, Ziegler SF, Artis D. Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation. Mucosal Immunol. 2020;.

Kelsen JR, Baldassano RN, Artis D, Sonnenberg GF. Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol. 2015;1(5):462-476.

Kelsen JR, Dawany N, Moran CJ, Petersen B-S, Sarmady M, Sasson A, Pauly-Hubbard H, Martinez A, Maurer K, Soong J, Rappaport E, Franke A, Keller A, Winter HS, Mamula P, Piccoli D, Artis D, Sonnenberg GF, Daly M, Sullivan KE, Baldassano RN, Devoto M. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology. 2015;149(6):1415-24.

Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, Deniz Y, Rowe P, Cyr S. Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases. J Allergy Clin Immunol. 2023;.

Kim M, Galan C, Hill AA, Wu W-J, Fehlner-Peach H, Song HWon, Schady D, Bettini ML, Simpson KW, Longman RS, Littman DR, Diehl GE. Critical Role for the Microbiota in CXCR1 Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses. Immunity. 2018;49(1):151-163.e5.

Kirii Y, Magarian-Blander J, Alter MD, Kotera Y, Finn OJ. Functional and molecular analysis of T cell receptors used by pancreatic- and breast tumor- (mucin-) specific cytotoxic T cells. J Immunother. 1998;21(3):188-97.

Kivolowitz C, Abdulhamid A, Victorio D, Castellanos J, Simpson K, Scherl E, Longman RS. O-006 Expansion of Immunologically-Relevant E. Coli in the Intestinal Microbiota of Patients with IBD-Associated Spondyloarthritis Promotes Mucosal RORgt-Dependent Immunity. Inflamm Bowel Dis. 2016;22 Suppl 1:S3.

Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar A-L, Kabata H, Monticelli LA, Moriyama S, Putzel GGarbès, Rakhilin N, Shen X, Kostenis E, König GM, Senda T, Carpenter D, Farber DL, Artis D. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature. 2017;549(7671):282-286.

Klose CSn, Artis D. Neuronal regulation of innate lymphoid cells. Curr Opin Immunol. 2019;56:94-99.